Translational Development Acquisition Corp. (TDAC) Stock Ticker
Market factors today
Unlock the full TDAC picture
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
TDAC stock facts
| Ticker symbol | TDAC |
| Exchange | NASDAQ Capital Market |
| Sector | Financial Services |
| Industry | Shell Companies |
| Market cap | $267.7M |
| CEO | Michael Hoffman |
| Employees | 2 |
| Headquarters | New York City, NY, US |
| IPO date | 2025-02-20 |
| Website | www.translational-development.com |
What you can see for TDAC on Tickr
Live TDAC price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TDAC report.
Rankings
FAQ
What is the ticker symbol for Translational Development Acquisition Corp.?
The ticker symbol for Translational Development Acquisition Corp. is TDAC, listed on the NASDAQ Capital Market.
What is TDAC?
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.